Navigation Links
The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
Date:12/8/2011

JERUSALEM, December 8, 2011 /PRNewswire/ --

The Joint Management Authority of the European Neighbourhood and Partnership Instrument (ENPI CBC MED program) has informed Prof Nava Ben Zvi, President of Hadassah College in Israel that they will award a contract of up to 2 million Euro for the Bio-Xplore Project. This project, initiated and directed by Hadassah College, will be implemented in partnership with the Biodiversity and Environmental Research Center of the Palestinian Authority, Leitat Technological Center in Spain, and the Hellenic Regional Development Center in Greece. Two US-based Universities Rutgers University, New Jersey and the North Carolina State University, will also participate in the project.

Prof Bertold Fridlender, Director of Hadassah College's Biotechnology Department is the inspiration and driving force behind the BioXplore project. He explained: "the goal of the project is to identify endemic plants from the Mediterranean area, which contain compounds that may be valuable for industrial products such as pharmaceutical products, food additives, cosmetics and others. This collaborative research will promote social and financial developments in the Mediterranean Sea Basin Area."

As part of the Bio-Xplore project, a Mediterranean branch of the Global Institute for Bio-Exploration (GIBEX-MED) will be created. The GIBEX (http://www.gibex.org) centers are active today in Africa, America and Asia, and aim to initiate and support international joint research and development. These joint activities promote the development of biological products based on natural resources endemic to each of the partnering countries. The products are focused on achieving health and environmental targets in developing countries.  

Prof Nava Ben Zvi, President of Hadassah College, Jerusalem stated: "This program will enable collaboration on an academic level with industrial and business potential for each of the involved partners".

The project will be part of the curriculum of the Biotechnology Department in Hadassah College. The Department was founded to prepare students for joining the industrial workforce and continuing post graduate studies and research. According to Prof Fridlender: "The conditions, the knowledge and the minds in Israel today are an outstanding base for this project and we are confident in its success."  

Link to the program website:

http://www.enpicbcmed.eu/documenti/29_153_20111028122848.pdf

For more information: Yaniv Rosenberg, PR Hadassah College +972-50-4488962, yaniv@rcspr.co.il; Dan Shoshani, PR +972-523608508



'/>"/>
SOURCE Hadassah College
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
2. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
3. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
4. ApoA-I Data Presented at European Society of Cardiology Congress
5. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
6. Kuvan Receives Positive Opinion From CHMP for European Approval
7. Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
8. Elseviers PharmaPendium(TM) Adds European Medicines Agency (EMEA) Documents
9. European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia
10. PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress
11. Oslo and Toulouse Cancer Clusters Join Forces to Drive European Cancer Research Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Germany , March 29, 2017 QIAGEN ... STANDARD: QIA) today announced the U.S. launch of its ipsogen ... cleared by the U.S. Food and Drug Administration as a qualitative in vitro ... extracted from EDTA whole blood.* ... ipsogen JAK2 assay is processed on QIAGEN,s Rotor-Gene ® Q MDx ...
(Date:3/29/2017)... TIKVAH, Israel , March ... (NASDAQ: BCLI), a leading developer of adult ... financial results for the year ended December ... highly successful and pivotal year for Brainstorm, with a ... made on clinical, regulatory and operational fronts," said ...
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, Inc. ... and drug-delivery therapies, today announced that an Oncologic ... Drug Administration voted 11 to 0 that the ... injection was favorable for patients in the proposed ... and chronic lymphocytic leukemia. The FDA action date ...
(Date:3/29/2017)... ... March 29, 2017 , ... Bactana Animal Health, a ... the world’s food supply through enhancement of the gut microbiota, today announced the closing ... Connecticut Innovations , New York-based Sustainable Income Capital Management, LLC and a number of ...
Breaking Biology Technology:
(Date:2/14/2017)... Feb. 14, 2017  Wake Forest Baptist Medical Center ... new chief executive officer (CEO). Freischlag joins the medical ... D. McConnell , M.D., who last year announced that ... Medical Center, after leading it since 2008.   ... of Wake Forest Baptist,s academic health system, which includes ...
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
Breaking Biology News(10 mins):